Case Study
AI for Clinical Intelligence
Learn how a rapidly growing ACO expanded value-based care with Reveleer
79k
patients
89%
new patient data
62%
HCC reviewed by provider
Business challenge
An ACO planned to grow aggressively in 2023 but needed to better understand the health status of patient populations acquired into its network to improve care.
At the same time, legacy processes relied too heavily on professional coders to manually review clinical documentation and struggled to scale.
At the same time, legacy processes relied too heavily on professional coders to manually review clinical documentation and struggled to scale.
.svg)
Solution
Patient insights at the point of care
.svg)
The ACO explored solutions and partnered with Reveleer, believing our data acquisition capabilities and the speed and accuracy of our AI-enabled platform would best help scale their business.
Our AI synthesizes and analyzes a nationwide network of clinical data to create patient summaries with undiagnosed Hierarchical Condition Category (HCC) codes with links to supporting clinical documentation.
Reveleer pushes this information into provider workflows at the point of care for more precise, clinical decision making, such as earlier diagnosis detection.
Our AI synthesizes and analyzes a nationwide network of clinical data to create patient summaries with undiagnosed Hierarchical Condition Category (HCC) codes with links to supporting clinical documentation.
Reveleer pushes this information into provider workflows at the point of care for more precise, clinical decision making, such as earlier diagnosis detection.
75+
National and Regional HIEs
70k
Medical Groups
5800
Dialysis Centers
90%
Of All Hospitals
Clinical insights to drive better outcomes
The company leveraged Reveleer's Clinical Intelligence to cover more than 70,000 patients, supplementing their in-house data with Reveleer's data interoperability and AI-powered clinical insights. From the provider's perspective, the solution delivers timely, evidence-based clinical insights that directly impact patient outcomes while streamlining pre- and post-encounter workflows.
89%
Patients with new clinical data
62%
Had new HCCs reviewed by providers
0.13
RAF uplift opportunity across patient populations
<2 Weeks
Retrieval time compared to months prior to Reveleer solution
Next steps
The ACO continues to work with Reveleer to on-board new provider groups, arming them with clinical insights that create opportunities for early detection and better care. As the ACO grows through acquisitions, it gains access to new populations, making it crucial to quickly and accurately assess the health status of their new patients. A more complete understanding enables the ACO to provide more targeted and effective care.
